Business Context and Reporting Period
Company: INTELLIGENT BIO SOLUTIONS INC.
Filing Type: Form 8-K (Current Report)
Date of Report: September 10, 2026
Reporting Period: As of the close of business on September 10, 2026
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a capital structure update.
Material Changes
The Company reported an update to its total outstanding shares of common stock resulting from two specific events:
- Exercise of previously disclosed outstanding prefunded warrants to purchase 285,000 shares of common stock.
- Issuance of 4,333 shares of restricted common stock pursuant to the Investor Relations and Corporate Development Advisory Agreement dated February 29, 2024.
Total Outstanding Shares: 3,316,803 shares as of September 10, 2026.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, risks, contingencies, or unusual items beyond the share count update.
Investor Verification Checklist
- Verify the total share count of 3,316,803 in subsequent filings or stock exchange data.
- Confirm the terms and status of the prefunded warrants exercised (285,000 shares).
- Review the Investor Relations and Corporate Development Advisory Agreement dated February 29, 2024, to understand the vesting or restrictions on the 4,333 issued shares.